The severe presentation and poor outcomes of rheumatic heart disease in Namibia: Lessons from the REMEDY study
DOI:
https://doi.org/10.7196/SAMJ.2022.v113i3b.16831Keywords:
Rheumatic DiseasesAbstract
Background. This paper reports the baseline characteristics and outcomes of 266 Namibian patients in the Global Registry of Rheumatic Heart Disease.
Objective. To describe clinical findings and outcomes in a cohort of children and adults with rheumatic heart disease in Namibia.
Methods. Prospective study of all patients with rheumatic heart disease at Windhoek Central Hospital between January 2010 and November 2012.
Results. A total of 266 patients were enrolled; median age was 22 years, 72.6% were <30 years old and 60.5% female. The majority (62.8%) had moderate-severe disease; 48.9% were in congestive cardiac failure. Secondary antibiotic prophylaxis was used by 34.2%. Warfarin was used by 75.3% (n=64/85) with clinical indications. Forty-seven (17.6%) had previous valve interventions, of whom 40 (15.0%) had mechanical valve replacements. Over a 2-year follow-up period 19.1% of patients died. Severe valve involvement at enrolment was independently associated with mortality (24.6% v. 5.1% in those without severe disease; hazard ratio 4.9; 95% confidence interval 1.50 - 15.98). Sixty-five (29.8%) of the 218 without previous intervention had valvular intervention after enrolment.
Conclusions. In Namibia rheumatic heart disease affects young people who present with severe disease and have a high case fatality rate. Rates of secondary prevention were low. These findings have informed the National Programme for Prevention and Control of Rheumatic Heart Disease in Namibia.
References
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group a streptococcal diseases. Lancet Infect Dis 2005; 5(11): 685-694. https://doi.org/10.1016/S1473-3099(05)70267-X
Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart Disease, 1990–2015. N Engl J Med 2017;377(8):713-722. https://doi.org/10.1056/NEJMoa1603693d 3. PaarJA,BerriosNM,RoseJD,etal.Prevalenceofrheumaticheartdiseaseinchildrenandyoungadultsin
Nicaragua. Am J Cardiol 2010;105(12):1809-1814. https://doi.org/10.1016/j.amjcard.2010.01.364
Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012;172(18):1386-1394. https://doi.org/10.1001/
archinternmed.2012.3310
Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012;379(9819):953- 64. PubMed PMID: 22405798. https://doi.org/10.1016/S0140-6736(11)61171-9
Karthikeyan G, Zühlke L, Engel M, et al. Rationale and design of a Global Rheumatic Heart Disease Registry: The REMEDY study. Am Heart J 2012;163(4):535-540.e1. https://doi.org/10.1016/j. ahj.2012.01.003
NewsholmeA.TheMilroyLecturesontheNaturalHistoryandAffinitiesofRheumaticFever:Delivered before the Royal College of Physicians of London, March, 1895. Br Med J 1895;1(1785):581-583.
Bland EF, Duckett Jones T. Rheumatic fever and rheumatic heart disease: A twenty year report on 1000 patients followed since childhood. Circulation 1951;4(6):836-843.
Government of Namibia: About Namibia: The Land and Population. http://www.gov.na/population (accessed 23 March 2017).
Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015;36(18):1115-1122a. https://doi.org/10.1093/eurheartj/ehu449
ZühlkeL,KarthikeyanG,EngelME,etal.Clinicaloutcomesin3343childrenandadultswithrheumatic heart disease from 14 low- and middle-income countries: Two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation 2016;134(19):1456-1466. https://doi. org/10.1161/circulationaha.116.024769
World Bank. World Bank Country and Lending Groups. 2016. https://datahelpdesk.worldbank.org/ knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed 22 September 2022).
World Health Organization, Global Health Repository Data. 2016. www.who.int/gho/data (accessed 23 March 2017).
Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: Incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 2013;128(5):492-501. https://doi.org/10.1161/circulationaha.113.001477
MocumbiAO,SliwaK.Women’scardiovascularhealthinAfrica.Heart2012;98(6):450-455.
Sliwa K, Mayosi BM. Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart 2013;99(18):1317-1322. https://doi.org/10.1136/
heartjnl-2011-301025
Diao M, Kane A, Ndiaye MB, et al. Pregnancy in women with heart disease in sub-Saharan Africa. Arch Cardiovasc Dis 2011;104(6-7):370-374. PubMed PMID: 21798468. https://doi.org/10.1016/j. acvd.2011.04.001
The World Bank. Indicators: Maternal Mortality Ratio 2015 www.data.worldbank.org/indicator/SH.STA. MMRT (accessed 30 June 2017).
ManyembaJ,MayosiBM.Penicillinforsecondarypreventionofrheumaticfever.CochraneDatabaseSys Rev 2002(3). PubMed PMID: 12137650 https://doi.org/10.1002/14651858.CD002227
Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever: A systematic review. S Afr Med J 2003;93(3):212-218.
Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013;10(5):284-92. https://doi.org/10.1038/nrcardio.2013.34
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: Executive summary: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(23):2440-2492. https://doi.org/10.1016/j.jacc.2014.02.537
Hugo-Hamman C, Forster N. National Advisory Committee for the Prevention and Control of Rheumatic Fever and Rheumatic Heart Disease in Namibia. Cardiovasc J Afr 2015;26(6):251. PubMed PMID: 26659439
MayosiB,RobertsonK,VolminkJ,etal.TheDrakensbergdeclarationonthecontrolofrheumaticfever and rheuma tic heart disease in Africa. S Afr Med J 2006;96(3 Pt 2):246.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 T Auala, L Zühlke, L Sikwaya, H du Toit, G Karthikeyan, K Teo, S Yusuf, M E Engels, B M Mayosi, C T Hugo-Hamman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
